Company profile

EXORPHIA company profile

EXORPHIA is a biotechnology startup focused on creating innovative medicines through the use of extracellular vesicles. The company is involved in the research, development, production, and marketing of exosome-based drugs derived from human cells. EXORPHIA operates in two primary sectors: the Drug Discovery Business, which seeks to commercialize exosomes for pharmaceutical applications, and the Non-Drug Discovery Business, which markets exosomes as raw materials for non-medical products.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2019-05-07

Headquarters

Headquarters
Tokyo, Tokyo, Japan
Postal code
100-0004
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$4.4M
Last funding
Corporate Round / 2025-08-20
Last equity funding
Corporate Round
Investors
3
Lead investors
3
Founders
1
Articles
1

Founders and investors

Founders

Koji Kuchiishi

Lead investors

D3Keio Innovation InitiativeRohto Pharmaceutical

Investors

D3Keio Innovation InitiativeRohto Pharmaceutical

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.